国家医保药品目录新增114种药品

Core Insights - The National Healthcare Security Administration (NHSA) has released the 2025 version of the National Basic Medical Insurance, Maternity Insurance, and Work Injury Insurance Drug Catalog, along with the first edition of the Commercial Health Insurance Innovative Drug Catalog, marking the eighth consecutive year of adjustments to the national drug catalog [1][2] Group 1: Drug Catalog Adjustments - The new drug catalog will be officially implemented starting January 1, 2026, replacing the 2024 version [1] - A total of 114 new drugs have been added to the 2025 National Medical Insurance Drug Catalog, with 50 being innovative drugs, resulting in an overall success rate of 88%, a significant increase from 76% in 2024 [3] - The total number of drugs in the adjusted National Medical Insurance Drug Catalog has increased to 3,253, including 1,857 Western medicines and 1,396 traditional Chinese medicines [4] Group 2: Coverage and Management - The NHSA emphasizes the need to strengthen the management of the medical insurance payment scope, ensuring that only drugs that align with diagnosis, treatment, and legal indications are covered [2] - The NHSA is promoting the inclusion of the innovative drug catalog in commercial health insurance coverage, encouraging the development of multi-tiered medical security systems [2][4] - The new catalog includes drugs that address gaps in basic medical insurance, covering treatments for major diseases such as triple-negative breast cancer, pancreatic cancer, and rare diseases like Gaucher disease [4]